Prelude Therapeutics, Inc. (PRLD)
4.33
-0.17
(-3.78%)
USD |
NASDAQ |
May 21, 16:00
4.63
+0.30
(+6.93%)
After-Hours: 19:59
Prelude Therapeutics Total Liabilities (Quarterly) : 59.46M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Myriad Genetics, Inc. | 336.30M |
| Sana Biotechnology, Inc. | 254.35M |
| ACADIA Pharmaceuticals, Inc. | 357.16M |
| Agenus, Inc. | 414.44M |
| Alnylam Pharmaceuticals, Inc. | 4.054B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 119.64M |
| Shareholders Equity (Quarterly) | 60.18M |
| Debt to Equity Ratio | 0.2945 |
| Current Ratio | 2.028 |
| Net Debt Paydown Yield | 0.03% |